Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARDELYX, INC. | Director | Common Stock | 230K | $1.53M | $6.65 | Jun 14, 2024 | Direct |
ARDELYX, INC. | Director | Stock Option (Right to Buy) | 40.2K | $93.4K | $2.32 | Jun 14, 2024 | Direct |
Adaptimmune Therapeutics PLC | Chief Operating Officer | American Depositary Shares representing Ordinary Shares | 20.2K | $13.6K | $0.67 | Jan 17, 2024 | Direct |
Adaptimmune Therapeutics PLC | Chief Operating Officer | Option to purchase Ordinary Shares | 565K | Jan 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARDX | ARDELYX, INC. | Jun 14, 2024 | 2 | $0 | 4 | Jun 17, 2024 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jan 16, 2024 | 3 | -$16.4K | 4 | Jan 17, 2024 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 15, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 11, 2024 | 2 | -$7.81K | 4 | Jan 12, 2024 | Chief Operating Officer |
ARDX | ARDELYX, INC. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jan 17, 2023 | 1 | -$8.25K | 4 | Jan 17, 2023 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 17, 2023 | 3 | $0 | 4 | Jan 17, 2023 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 11, 2023 | 2 | -$15.2K | 4 | Jan 12, 2023 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 4, 2023 | 1 | -$6.07K | 4 | Jan 4, 2023 | Chief Operating Officer |
ARDX | ARDELYX, INC. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jan 18, 2022 | 1 | -$13.9K | 4 | Jan 18, 2022 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 12, 2022 | 2 | $0 | 4 | Jan 13, 2022 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 11, 2022 | 2 | -$21.4K | 4 | Jan 13, 2022 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jan 4, 2022 | 1 | -$14.2K | 4 | Jan 5, 2022 | Chief Operating Officer |
ADAP | Adaptimmune Therapeutics PLC | Jul 2, 2021 | 1 | -$18.7K | 4 | Jul 2, 2021 | Chief Operating Officer |
ARDX | ARDELYX, INC. | Jun 16, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |